Skip to main content
. 2017 May;45(5):532–539. doi: 10.1124/dmd.116.074872

Fig. 6.

Fig. 6.

No PB-promoted HCC in CAR KO mice. Car−/− (CAR KO) and Car+/+ (CAR WT) mice with a C3H/HeNCrlBR background were treated with a single dose of diethylnitrosamine for tumor initiation and chronically with PB for tumor promotion, according to a standard protocol of two-step hepatocarcinogenesis (Yamamoto et al., 2014). After 32-week PB treatment, 8 of 20 Car+/+ mice developed carcinoma, whereas none of the 20 Car−/− mice did. DEN, diethylnitrosamine; WT, wild type.